fbpx
    • Myeloma Crowd Newsroom
    • Jul 11, 2014

    Cure Magazine Features Chemo Brain Doc Notes smartphone app

June 15, 2014

Cure Magazine features the Chemo Brain Doc Notes app created by myeloma patient and Myeloma Crowd founder Jenny Ahlstrom in their June 2014 issue. Chemo Brain Doc Notes is a free iOS and Android app that helps patients remember the important questions for their next visit. For more about Chemo Brain Doc Notes, read more here.

Read the Cure Magazine article here.

 

About Author

Jenny A

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA

Please enter the correct captcha code to verify that you are human.

MYELOMA CROWD RESEARCH INITIATIVE
$162958 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal

AmazonSmile
More Articles
myeloma

Life With Multiple Myeloma

Myeloma Patients, Partnership and Education

Aug 13, 2019

By Bonnie Falbo As the wife of a myeloma patient, and as a new Myeloma Coach for the Myeloma Crowd, I was honored to attend the Inaugural Charlotte Plasma Cell Disorder Congress, hosted by Levine Cancer Institute on August 9-11, 2019. Intended primarily for local health care providers who treat myeloma patients, Myeloma Coaches and […]

Multiple Myeloma News

When and How to Treat Smoldering Multiple Myeloma

Aug 21, 2019

Smoldering multiple myeloma was first defined in 1980 by Drs. Kyle and Greipp as “an asymptomatic plasma cell disorder.”  The annual risk of progression from smoldering myeloma to symptomatic multiple myeloma is 10% per year for the first 5 years, 5% per year during the following 5 years and only 1% per year after 10 years. […]

Myeloma Clinical Trials

Clinical Trial: Daratumumab, Ixazomib, and Dexamethasone With or Without Bortezomib in Patients With Newly Diagnosed Multiple Myeloma (DeRIVE)

May 23, 2019

A phase II study is open evaluating how well daratumumab, ixazomib, and dexamethasone work with or without bortezomib in treating patients with newly diagnosed multiple myeloma. Please not that for one of the patient groups, it will use two different types of proteasome inhibitors in consecutive order.  Open-Label: Patients and their doctors will know both the […]

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors: